Boston, MA 02/20/2014 (wallstreetpr) – Inovio Pharmaceuticals Inc (NYSEMKT:INO) has announced that its CEO and President Joseph Kim will present at the 34th Annual health Care Conference organized by Cowen and Company. The executive will walk investors, analysts and consumers through the company’s corporate overview during the conference in Boston. The INO presentation is scheduled for March 3, at around 2.50 PM ET. This announcement was preceded by the expanding of the company’s senior management team where two key appointments were made, hoped to help the company advance its clinical and preclinical pipeline. Inovio Pharmaceuticals Inc (NYSEMKT:INO) traded downward in the regular market session whereby each of its shares lost 4 cents, but the post-market session was characterized by gains whereby each share added 7 cents to its value.
United States Steel Corporation (NYSE:X): The announcement that the U.S. Department of Commerce will not impose traffics on South Korea steel pipes was a source of hurting news for X, and perhaps its other steel peers in the U.S. The stock lost more than 7 percent of its market value in the last session and each shares concluded the day $24.86. It was a day that saw a significantly higher volume of shares exchanging hands. Currently analysts at TheStreet view the stock as “hold” and cite among other strength areas solid stock performance and big stock price movement. Yet it also bears weaknesses in areas such as higher debt management risk, poor return on equity and weakening net income.
JPMorgan Chase & Co. (NYSE:JPM) has announced February 25, its Investor Day whereby CEO Jamie Dimon and executive members of the company will present in New York City. The presentation which is expected to start at 8.30 a.m. (Eastern) and conclude at 3.30 p.m. (Eastern) will include among other things, question and answer session. Everybody else can access the New York City proceedings through a live audio webcast. The stock of JPMorgan Chase & Co. (NYSE:JPM) lost 2.1 percent in the previous session, leading the share to conclude at the price of $57.26 each, however, a gain of 11 cents per share realized in the post-market session.
